TYVYT
Mankind Pharma inks licensing pact with Innovent to commercialise Sintilimab in IndiaMankind Pharma Ltd and Innovent Biologics have partnered to license and commercialise the cancer immunotherapy drug Sintilimab in India. Th...
Mankind Pharma partners with Innovent to aid cancer treatment in IndiaMankind Pharma has partnered with Innovent Biologics to bring sintilimab, a PD-1 immunotherapy, to India. The drug treats various cancers a...
- Load More